Antibiotic selection in the management of febrile neutropenia: Current approach and new directions
Braz. j. infect. dis
;
2(3): 109-17, Jun. 1998.
Artículo
en Inglés
| LILACS
| ID: lil-243406
RESUMO
The combination of neutropenia and fever, with or without documented infection, is a commun complication in cancer patients receiving chemotherapy. The prompt institution of empirical broad-spectrum antibiotic therapy for febrile neutropenic patients has been shown to reduce the rate of early death and morbidity in cancer populations undergoing chemotherapy. Three different regimens for considerations as initial empiric therapy are presented. Alternatives such as outpatient regimens to low risk patients and monotherapy are discussed. If confirmed prospectively, the results presented here may enable clinicians to identify low risk groups and treat neutropenia and fever with good results and better economic and psychological cost.
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Carbapenémicos
/
Cefalosporinas
/
Agranulocitosis
/
Evaluación de Medicamentos
/
Fiebre
/
Neoplasias
/
Neutropenia
/
Antineoplásicos
Tipo de estudio:
Estudio de etiología
Límite:
Humanos
Idioma:
Inglés
Revista:
Braz. j. infect. dis
Asunto de la revista:
Enfermedades Transmisibles
Año:
1998
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS